Ferritin level: A predictor of severity and mortality in hospitalized COVID-19 patients

Introduction: This study aims to investigate in-hospital mortality in severe acute respiratory syndrome coronavirus 2 patients stratified by serum ferritin levels. Methods: Patients were stratified based on ferritin levels (ferritin levels <= 1000 or >1000). Results: Approximately 89% (118) of the patients with ferritin levels > 1000 had pneumonia, and 51% (67) had hypertension. Fever (97, 73.5%) and shortness of breath (80, 61%) were two major symptoms among the patients in this group. Logistic regression analysis indicated that ferritin level (odds ratio [OR] = 0.36, 95% confidence interval [CI] = 0.21-0.62; p < .001), male sex (OR = 2.63, 95% CI = 1.43-5.06; p = .003), hypertension (OR = 4.16, 95% CI = 2.42-7.36; p < .001) and pneumonia (OR = 8.48, 95% CI = 3.02-35.45; p < .001) had significance in predicting in-hospital mortality. Additionally, the Cox proportional hazards analysis and Kaplan-Meier survival probability plot showed a higher mortality rate among patients with ferritin levels > 1000. Conclusion: In this study, higher levels of serum ferritin were found to be an independent predictor of in-hospital mortality.

Automated summary

This study investigated in-hospital mortality in severe acute respiratory syndrome coronavirus 2 patients stratified by serum ferritin levels. The results showed that higher levels of serum ferritin, along with hypertension and pneumonia, were associated with predicting in-hospital mortality. Patients with ferritin levels > 1000 had a higher mortality rate.